Sabine Strommer Selected Research

Tetraspanin 30

1/2014

Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabine Strommer Research Topics

Disease

12	Neoplasms (Cancer) 11/2012 - 12/2002
6	Stomach Neoplasms (Stomach Cancer) 08/2011 - 10/2006
5	Melanoma (Melanoma, Malignant) 01/2014 - 12/2002
2	Hypoxia (Hypoxemia) 11/2008 - 09/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Leukemia 01/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Necrosis 09/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2006
1	Communicable Diseases (Infectious Diseases) 02/2004
1	Splenomegaly 12/2002

Drug/Important Bio-Agent (IBA)

3	Antisense OligonucleotidesIBA 03/2011 - 12/2002
3	Everolimus FDA Link 10/2010 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 10/2006 - 12/2002
2	Sunitinib (Sutent)FDA Link 01/2014 - 10/2010
2	Docetaxel (Taxotere)FDA Link 01/2014 - 10/2006
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 11/2008
2	tariquidar (XR9576)IBA 11/2012 - 01/2012
2	dactolisibIBA 01/2012 - 08/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2011 - 02/2011
2	Phosphotransferases (Kinase)IBA 03/2011 - 02/2011
2	Biological ProductsIBA 03/2011 - 10/2006
2	Mechanistic Target of Rapamycin Complex 1IBA 02/2011 - 09/2008
2	TOR Serine-Threonine KinasesIBA 02/2011 - 11/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010 - 09/2008
2	Caspase 3 (Caspase-3)IBA 11/2008 - 09/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2008 - 09/2008
2	OligonucleotidesIBA 10/2006 - 02/2004
2	Interleukin-12 (IL 12)IBA 02/2004 - 12/2002
1	AntigensIBA 01/2014
1	CytokinesIBA 01/2014
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2014
1	Surface Antigens (Surface Antigen)IBA 01/2014
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2014
1	Adapalene (Differin)FDA LinkGeneric 01/2014
1	Nerve Growth Factor (NGF)IBA 01/2014
1	Tetraspanin 30IBA 01/2014
1	6,7- dimethoxy- 2- (4- methoxybiphenyl- 4- yl- methyl)- 1,2,3,4- tetrahydroisoquinolineIBA 11/2012
1	ElacridarIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	Verapamil (Calan)FDA LinkGeneric 01/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2012
1	alovudineIBA 08/2011
1	LipidsIBA 03/2011
1	sphingosine kinaseIBA 03/2011
1	RNA (Ribonucleic Acid)IBA 03/2011
1	locked nucleic acidIBA 03/2011
1	Mechanistic Target of Rapamycin Complex 2IBA 02/2011
1	PI103IBA 02/2011
1	Sirolimus (Rapamycin)FDA Link 02/2011
1	AntibodiesIBA 12/2008
1	HMW-MAAIBA 12/2008
1	Immunoglobulin G (IgG)IBA 12/2008
1	VaccinesIBA 12/2008
1	Alkylating AgentsIBA 11/2008
1	Cisplatin (Platino)FDA LinkGeneric 10/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	GuanosineIBA 02/2004
1	CytidineIBA 02/2004
1	oblimersen (G3139)IBA 12/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 03/2011 - 10/2006
2	Therapeutics 03/2011 - 01/2006
2	Heterologous Transplantation (Xenotransplantation) 02/2004 - 12/2002
1	Castration 01/2014
1	Immunotherapy 12/2008
1	Subcutaneous Injections 02/2004